OPKO Health, Inc.

US$1.73As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:OPKHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (15.56%)
Div yield —
ROE (8.90%)
Diagnostics & Research
Beta (5Y) 1.53
PE TTM —
TSR TTM 27.21%
Mkt cap US$1.285B
ROIC (14.35%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.91
10.26%
(92.91%)
Hold 7|12|10|3|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.04
20.86%
7.09%
10.49%
3.23%
Revenue$M
89.81
90.08
88.06
87.91
5.12%
2.00%
(0.73%)
(2.38%)
Peers (US$1.285B)
Cap (US$)
PE
1.712B
—
1.094B
—
1.279B
19.87x
Capital
TTM
5Y
10Y
Leveragex
1.268
0.232
0.205
EBIT/Intx
0.743
0.546
0.455
Own earn%
256.31
63.69
86.71
Sh yield%
18.63
2.21
3.55
Owners
Insiders/Inst%
3.11
56.22
Short interest%
4.67
SBC / revenue%
0.61
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
4–11
$1 testx
—
Incr. ROIC%
4